Predicting the risk of pancreatic cancer using clinical and genetic data
Pancreatic Cancer Risk Prediction: Integrating Individual-Level Clinical and Genetic Data
['FUNDING_OTHER'] · VA CONNECTICUT HEALTHCARE SYSTEM · NIH-10950328
This study is looking to improve how we predict the risk of pancreatic cancer, especially for Black individuals who often find out about it later, by using personal health and genetic information to spot those at higher risk so they can get help sooner.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VA CONNECTICUT HEALTHCARE SYSTEM (nih funded) |
| Locations | 1 site (WEST HAVEN, UNITED STATES) |
| Trial ID | NIH-10950328 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the prediction of pancreatic ductal adenocarcinoma (PDAC) risk by integrating individual-level clinical and genetic data. It focuses on identifying high-risk individuals, particularly among Black populations who are diagnosed at later stages of the disease. By utilizing data from various biobanks and datasets, the study seeks to develop a more effective algorithm for risk assessment that goes beyond traditional methods. This approach will help in identifying asymptomatic adults who may be at increased risk for PDAC, allowing for earlier intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research include asymptomatic adults, particularly those of African descent, who may be at higher risk for pancreatic cancer.
Not a fit: Patients with a known hereditary predisposition to pancreatic cancer may not benefit from this research as they are already under existing screening protocols.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and prevention strategies for pancreatic cancer, potentially saving lives.
How similar studies have performed: Previous research has shown promise in using integrated clinical and genetic data for cancer risk prediction, suggesting that this approach could be effective.
Where this research is happening
WEST HAVEN, UNITED STATES
- VA CONNECTICUT HEALTHCARE SYSTEM — WEST HAVEN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WANG, LOUISE L — VA CONNECTICUT HEALTHCARE SYSTEM
- Study coordinator: WANG, LOUISE L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.